Immunoblot Analysis and Band Depletion Assays

Methods in Molecular Biology

Volumn 94, Issue , 1999, Pages 253-268

  Kaufmann, Scott H ^a   Svingen, Phyllis A ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

Covalent Adduct; Full Loading; Guanidine Hydrochloride; Human Leukemia Cell; Transfer Apparatus

Indexed keywords

2 (2 DIMETHYLAMINOETHYL) 9 METHOXY 5 NITROPYRAZOLO[3,4,5 KL]ACRIDINE; ACRIDINE DERIVATIVE; ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE; PYRAZOLE DERIVATIVE; TOPOTECAN;

ARTICLE; CELL STRAIN K 562; DNA ADDUCT; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOBLOTTING; LEUKEMIA; METABOLISM; METHODOLOGY; PATHOLOGY;

ACRIDINES; ANTINEOPLASTIC AGENTS; DNA ADDUCTS; DNA TOPOISOMERASES, TYPE I; HUMANS; IMMUNOBLOTTING; K562 CELLS; LEUKEMIA; PYRAZOLES; TOPOTECAN;

MLCS; MLOWN;

EID: 4444380340     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1385/1-59259-259-7:253     Document Type: Chapter

References (34)

1. Gershoni, J. M. and Palade, G. E. (1983) Protein blotting: principles and applications. Anal. Biochem. 131, 1–15.
2. Beisiegel, U. (1986) Protein blotting. Electrophoresis 7, 1–18.
3. Stott, D. I. (1989) Immunoblotting and dot blotting. J. Immunol. Methods 119, 153–187.
4. Kaufmann, S. H. and Kellner, U. (1998) Erasure of Western blots after autorad-iography or chemiluminescent detection, in Methods in Molecular Biology, vol. 80 (Pound, J., ed.), Humana Press, Totowa, NJ, pp. 223–236.
5. Chen, A. Y. and Liu, L. F. (1994) DNA Topoisomerases: essential enzymes and lethal targets. Ann. Rev. Pharmacol. Toxicol. 34, 191–218.
6. Pommier, Y., Leteurtre, F., Fesen, M. R., Fujimori, A., Bertrand, R., Solary, E., Kohlhagen, G., and Kohn, K. W. (1994) Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest. 12, 530–542.
7. Froelich-Ammon, S. J. and Osheroff, N. (1995) Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J. Biol. Chem. 270, 21,429–21,432.
8. Tricoli, J. V. and Kowalski, D. (1983) Topoisomerase I from chicken erythrocytes: purification, characterization, and detection by a deoxyribonucleic acid binding assay. Biochemistry 22, 2025–2031.
9. Hsiang, Y.-H. and Liu, L. F. (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res. 48, 1722–1726.
10. Zwelling, L. A., Hinds, M., Chan, D., Mayes, J., Sie, K. L., Parker, E., Silberman, L., Radcliffe, A., Beran, M., and Blick, M. (1989) Characterization of an amsacrine-resistant line of human leukemia cells. Evidence for a drug-resistant form of topoisomerase II. J. Biol. Chem. 264, 16,411–16,420.
11. Hendricks, C. B., Rowinsky, E. K., Grochow, L. B., Donehower, R. C., and Kaufmann, S. H. (1992) Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SK&F 104864), a new camptothecin analogue. Cancer Res. 52, 2268–2278.
12. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N., and Poirier, G. G. (1993) Specific proteolytic fragmentation of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976–3985.
13. McGahon, A., Bissonnette, R., Schmitt, M., Cotter, K. M., Green, D. R., and Cotter, T. G. (1994) BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83, 1179–1187.
14. Kaufmann, S. H., McLaughlin, S. J., Kastan, M., Liu, L. F., Karp, J. E., and Burke, P. J. (1991) Topoisomerase II levels during granulocytic maturation in vitro and in vivo. Cancer Res. 51, 3534–3543.
15. James, G. T. (1978) Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers. Anal. Biochem. 86, 574–579.
16. English, D. and Andersen, B. R. (1974) Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-hypaque. J. Immunol. Methods 5, 249–252.
17. Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150, 76–85.
18. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685.
19. Parekh, B. S., Mehta, H. B., West, M. D., and Montelaro, R. C. (1985) Preparative elution of proteins from nitrocellulose membranes after separation by sodium dodecylsulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 148, 87–92.
20. Salinovich, O. and Montelaro, R. C. (1986) Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodceylsulfate-polyacrylamide gel electrophoresis. Anal. Biochem. 156, 341–347.
21. Kaufmann, S. H. (1991) Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line. Cancer Res. 51, 1129–1136.
22. Kaufmann, S. H. (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res. 49, 5870–5878.
23. Tanizawa, A., Fujimori, A., Fujimori, Y., and Pommier, Y. (1994) Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials. J. Natl. Cancer Inst. 86, 836–842.
24. Heck, M. M., Hittelman, W. N., and Earnshaw, W. C. (1988) Differential expression of DNA topoisomerase I and II during the eukaryotic cell cycle. Proc. Natl. Acad. Sci. USA 85, 1086–1090.
25. Amrein, P. C. and Stossel, T. P. (1980) Prevention of degradation of human polymorphonuclear leukocyte proteins by diisopropylfluorophosphate. Blood 56, 442–447.
26. Fish, W. W., Reynolds, J. A., and Tanford, C. (1970) Gel chromatography of proteins in denaturing solvents. Comparison between sodium dodecyl sulfate and guanidine hydrochloride as denaturants. J. Biol. Chem. 245, 5166–5168.
27. Kaufmann, S. H., Karp, J. E., Jones, R. J., Miller, C. B., Schneider, E., Zwelling, L. A., Cowan, K., Wendel, K., and Burke, P. J. (1994) Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood 83, 517–530.
28. Pampori, N. A., Pampori, M. K., and Shapiro, B. H. (1995) Dilution of the chemi-luminescence reagents reduces the background noise on western blots. Biotechniques 18, 588–590.
29. Shea, T. B. (1994) Technical report. An inexpensive densitometric analysis system using a Macintosh computer and a desktop scanner. Biotechniques 16, 1126–1128.
30. Hsiang, Y. H. and Liu, L. F. (1989) Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons. J. Biol. Chem. 264, 9713–9715.
31. Kaufmann, S. H., Svingen, P. A., Gore, S. D., Armstrong, D. K., Cheng, Y-C., and Rowinsky, E. K. (1997) Altered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells. Blood 89, 2098–2104.
32. Slichenmyer, W. J., Rowinsky, E. K., Donehower, R. C., and Kaufmann, S. H. (1993) The current status of camptothecin analogues as antitumor agents. J. Natl. Cancer Inst. 85, 271–291.
33. Kaufmann, S. H., Charron, M., Burke, P. J., and Karp, J. E. (1995) Changes in topoisomerase I levels and subnuclear localization during myeloid maturation in vitro and in vivo. Cancer Res. 55, 1255–1260.
34. Desnoyers, S., Kaufmann, S. H., and Poirier, G. G. (1996) Alteration of the nucle-olar localization of poly(ADP-ribose) polymerase upon treatment with transcription inhibitors. Exp. Cell Res. 227, 146–153.